Biotechnology Program/RENORBIO, Health Sciences Center, Federal University of Espírito Santo, Vitoria (Espírito Santo), Brazil.
Department of Pharmaceutical Sciences, Federal University of Espirito Santo, Marechal Campos Avenue, MaruípeEspírito Santo, Vitória, 1468, Brazil.
Cell Commun Signal. 2023 Jun 27;21(1):161. doi: 10.1186/s12964-023-01178-1.
Breast cancer (BC) is the second most frequent type of cancer in the world and most common among women, configuring a major challenge to global health. BC is a complex and heterogeneous disease that can be subdivided into distinct tumor types based on the expression of molecular markers predicting patient outcomes and response to therapy. A growing number of studies have tried to expand the known markers by investigating the association of altered lipid metabolism with BC immune escape, progression, and metastasis. In this review, we describe the metabolic peculiarities of each BC subtype, understanding how this influences its aggressiveness and identifying whether these intrinsic vulnerabilities of each subtype can play a role in therapeutic management and may affect immune system cells in the tumor microenvironment.
The evidence suggests so far that when changes occur in lipid pathways, it can affect the availability of structural lipids for membrane synthesis, lipid synthesis, and degradation that contribute to energy homeostasis and cell signaling functions. These findings will guide the next steps on the path to understanding the mechanisms underlying how lipids alterations are related to disparities in chemotherapeutic response and immune escape in BC. Video Abstract.
乳腺癌(BC)是世界上第二常见的癌症类型,也是女性中最常见的癌症,对全球健康构成了重大挑战。BC 是一种复杂且异质性的疾病,可以根据预测患者预后和对治疗反应的分子标志物的表达,进一步细分为不同的肿瘤类型。越来越多的研究试图通过研究脂质代谢的改变与 BC 的免疫逃避、进展和转移之间的关系来扩展已知的标志物。在这篇综述中,我们描述了每种 BC 亚型的代谢特点,了解这些特点如何影响其侵袭性,并确定这些亚型的内在脆弱性是否在治疗管理中发挥作用,并可能影响肿瘤微环境中的免疫系统细胞。
到目前为止,有证据表明,当脂质途径发生变化时,它可能会影响用于膜合成、脂质合成和降解的结构性脂质的可用性,这些脂质合成和降解有助于能量稳态和细胞信号转导功能。这些发现将指导我们进一步了解脂质改变与 BC 中化疗反应和免疫逃避差异之间关系的机制。